MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 57 filers reported holding MEREO BIOPHARMA GROUP PLC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $44 | +193.3% | 34,093 | +72.7% | 0.00% | +100.0% |
Q4 2022 | $15 | -99.9% | 19,745 | -41.7% | 0.00% | -33.3% |
Q3 2022 | $29,000 | -71.3% | 33,880 | -46.3% | 0.00% | -70.0% |
Q4 2021 | $101,000 | +236.7% | 63,045 | +416.7% | 0.01% | +233.3% |
Q3 2021 | $30,000 | -86.0% | 12,202 | -79.7% | 0.00% | -87.0% |
Q4 2020 | $215,000 | – | 59,966 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 1,854,278 | $6,638,000 | 3.61% |
Asymmetry Capital Management, L.P. | 739,812 | $2,649,000 | 1.21% |
Affinity Asset Advisors, LLC | 625,000 | $2,238,000 | 1.19% |
Tri Locum Partners LP | 728,710 | $2,609,000 | 0.95% |
Boxer Capital, LLC | 6,226,673 | $22,291,000 | 0.72% |
DAFNA Capital Management LLC | 668,148 | $2,392,000 | 0.71% |
Vivo Capital, LLC | 4,220,938 | $15,111,000 | 0.67% |
Delphi Management Partners VIII, L.L.C. | 256,734 | $919,000 | 0.60% |
SILVERARC CAPITAL MANAGEMENT, LLC | 280,000 | $1,002,000 | 0.58% |
Rubric Capital Management LP | 1,853,417 | $6,635,000 | 0.49% |